The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass

Roux-en-Y gastric bypass (RYGB) is efficient at inducing drastic albeit variable weight loss and type-2 diabetes (T2D) improvements in patients with severe obesity and T2D. We hypothesized a causal implication of the gut microbiota (GM) in these metabolic benefits, as RYGB is known to deeply impact...

Full description

Saved in:

Bibliographic Details
Published in:	Gut microbes Vol. 14; no. 1; p. 2050635
Main Authors:	Debédat, Jean, Le Roy, Tiphaine, Voland, Lise, Belda, Eugeni, Alili, Rohia, Adriouch, Solia, Bel Lassen, Pierre, Kasahara, Kazuyuki, Hutchison, Evan, Genser, Laurent, Torres, Licia, Gamblin, Camille, Rouault, Christine, Zucker, Jean-Daniel, Kapel, Nathalie, Poitou, Christine, Marcelin, Geneviève, Rey, Federico E., Aron-Wisnewsky, Judith, Clément, Karine
Format:	Journal Article
Language:	English
Published:	United States Taylor & Francis 31.12.2022 Taylor & Francis Group
Subjects:	Animals bacteroides Bacteroidetes bariatric surgery Body Weight clustering Diabetes Mellitus, Type 2 - microbiology diabetes remission fecal matter transplantation Gastric Bypass - methods Gastrointestinal Microbiome Humans Life Sciences Mice Microbiota obesity relapse Research Paper roux-en-Y gastric bypass type-2 diabetes Weight Loss bacteroides Microbiota bariatric surgery relapse type-2 diabetes diabetes remission clustering roux-en-Y gastric bypass obesity fecal matter transplantation
ISSN:	1949-0976, 1949-0984, 1949-0984
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!